ISOA Awards Funds to NeuroMolecular Pharmaceuticals

The Institute for the Study of Aging (ISOA), a biomedical venture philanthropy created to catalyze and fund drug discovery research for Alzheimer's disease, recently awarded a two-year program-related investment to NeuroMolecular Pharmaceuticals (NeuroMolecular). The funding will support a scientific research program aimed at improving the therapeutic properties of memantine.

Yahoo News (http://biz.yahoo.com/iw/050203/080241.html)